Promoting Food Access and Livelihoods for Vendors in Informal Settlements

Promoting Food Access and Livelihoods for Vendors in Informal Settlements

Kenya’s urban poor federation Muungano wa Wanavijiji is working with food vendors in informal settlements to reveal their challenges and explore how to promote food security. Muungano is a member of Slum Dwellers International (SDI), a network that aims to improve shelter, services, and government responsiveness to the urban poor. The ongoing project is complement-ing other Urban Zoo activities, as well as building upon Muungano’s past experience with grassroots data-collection and advo-cacy. Working alongside Muungano are community residents, pro-poor financial analysts at Akiba Mashinani Trust (Muungano’s financial wing), and researchers at University College London and UC Berkeley.

This action-research project is utilizing participatory methods to understand vendors in Nairobi’s informal settlements of Korogocho and Viwandani. Vendors sell a variety of items in these settlements such as fresh produce; meat, fish, and eggs; cooked and uncooked foods; beverages; and snacks. A mobile phone application is capturing vendors’ demographic and business profile, while base-maps and balloon-mapping (low-cost aerial photography with balloons and a simple camera) are generating detailed spatial data on their locations. Finally, focus group discussions (FGDs) are delving into traders’ constraints, coping strategies, and priorities for change.

These vendors are poorly organised and frequently overlooked or stigmatised by policy-makers, yet vending is a vital source of affordable, accessible foods and a key income-generating activity. Customers may appreciate the convenience and their personal relations with traders; food vending is also a widespread livelihood strategy, particularly for female traders seek-ing to combine work with childcare. As a female vendor explained in a Viwandani FGD, “I’ll be doing my work and also doing the house chores and also look after my kids…But if you are outside [the settlement], sometimes you have to look for someone to take care of your kids and sometimes you don’t have that money.”

However, vendors often face multiple challenges in their settlements like overflowing drains, minimal water and sanitation, uncollected rubbish, and elevated insecurity. In turn, widespread hazards and poor infrastructure or services can threaten food security by jeopardising vendors’ livelihoods and customers’ access to food. But the project’s maps and FGDs are uncovering these concerns and, moreover, a Food Vendors’ Association (FVA) has been established to increase their collective strength, amplify their voices, and advocate for much-needed interventions in the future.

This action-research project is utilizing participatory methods to understand vendors in Nairobi’s informal settlements of Korogocho and Viwandani, with support from APHRC and ILRI team members from the Urban Zoonoses project.

This article has been written by the Muungano team

Middle East Respiratory Syndrome Corona Virus (MERS-CoV) – What do we know?

Middle East Respiratory Syndrome Corona Virus (MERS-CoV) – What do we know?

In the summer of 2012 in Saudi Arabia a strange corona virus infection was isolated from a patient with acute pneumonia and renal failure. Subsequently, a series of laboratory diagnostics divulged a novel coronavirus later known as Middle East Respiratory Syndrome Coronavirus (MERS COV).

Following the virus identification, a new case was reported from a Qatar patient in the UK and a cluster of hospital cases were reported among health workers in Zarqa, Jordan. There was ineffable fear that the world was fronting another pandemic after the Severe Acute Respiratory Syndrome (SARS).

MERS-CoV worldwide distribution

As of June 3rd 2015, there have been 1,179 confirmed cases of MERS and 442 fatalities in 25 nations representing a case fatality rate of 37.49%. South Korea is the latest country to report two deaths and 35 cases in the largest outbreak outside Saudi Arabia. The vast majority of the South Korean cases have      been acquired from hospitals with the fast spread attributed to the fact that family members often stay with patients in their hospital rooms.

MERS-CoV infection in humans occurs either as outbreaks as witnessed in Jeddah, Saudi Arabia where 255 confirmed cases were reported in four months or as isolated cases. The infection’s clinical presentation ranges from asymptomatic to a very severe pneumonia with the acute respiratory distress syndrome, septic shock and multi-organ failure ensuing in death.

Serological studies have confirmed camels have antibodies against the virus. In addition, virus detection by reverse transcription PCR and sequencing has confirmed that these antibodies are likely to be caused by infection with a similar virus strains that infect humans, although a formal confirmation of the role of camels in the epidemiology of the virus is still elusive. Transmission has largely remained human to human with a few isolated primary cases having a histo-ry of contact with camels, suggesting that they are a source of human infection.

A number of questions regarding the dis-ease have remained difficult to answer:

  1. What is the reservoir of the virus, and are there multiple animal species that may form a reservoir community?   If yes, which ones?
  2. The infection has predominantly affect-ed older people.  Is this related to abil-ity to fight infection, or is it exposure related?
  3. The evolutionary background of MERS-CoV is unclear; antibodies against the virus were found in Kenyan camels during a period spanning from 1992 to 2013. This implies that the virus exist-ed in camels long before it was identified and before it jumped to the human population. Nevertheless, the appearance of human cases in the last few years might indicate some kind of mutation of virus that allows it be become human infective.  If this is the case, could it spread rapidly though the human population?  If this mutation has occurred, has it occurred in multiple locations simultaneously?
  4. What is the risk of human infection from camel populations outside the Middle East (eg in Kenya)

Performing nasal swabIn collaboration with a number of partners, including St Louis Zoo, the Mpala Research Center and the Erasmus Medical University, we are investigating elements of the epidemiology of MERS-CoV in camels in Kenya to help answer some of the above questions.

These studies are an extension of the Urban Zoo project’s activities investigating camel value chains in Kenya and Nairobi.

Article by Dishon Muloi (dshnmuloi@gmail.com)

Urban Zoo Project in the A4NH 2014 Annual report

Urban Zoo Project in the A4NH 2014 Annual report

1.6.2.1 A4NH Annual report 2014Zoonoses, or diseases that can pass between animals and humans, lead to 2.4 billion cases of illness and 2.2 million deaths per year, according to ILRI scientist, Delia Grace. The 13 major culprits include bacterial infections such as brucellosis and leptospirosis, as well as other infections, like bovine tuberculosis. It is estimated that more than 75 percent of diseases that have emerged over the past 20 years originated in animals.
Such diseases are particularly likely to develop when people and animals live in close proximity to each other, increasing the opportunity for the transfer of pathogens. With agricultural intensification stemming from increased consumer demand for milk and meat, animals and humans are increasingly crowded within the same space, often in unsanitary conditions. In Nairobi, more than 60 percent of the population lives around the edges of the city in crowded, informal settlements.
Most lack basic amenities, such as toilets, running water, and sewers. Many residents keep livestock close by, although it is illegal to keep animals within city limits. The United Nations predicts that these makeshift suburbs will continue to grow in Nairobi, surpassing six million people by 2025.
The Urban Zoo project is led by the University of Liverpool (UK) with a major funding award from the UK Environmental and Social Ecology of Human Infectious Diseases Initiative, led by the UK Medical Research Council, and is aligned to A4NH at ILRI. It looks at the health implications of changes in agriculture, particularly theintensification of livestock in urban and peri-urban areas. The project examines ways in which pathogens are introduced and spread through livestock commodity value chains among urban populations around Nairobi, Kenya.
The project includes nine academic partners in Kenya and the UK that coordinate with the Kenyan government and policy institutions as well as a network of INGOs. Urban Zoo research covers meat and milk value chains, human nutrition in poor urban populations (with additional funding from the Leverhulme Centre for Integrative Research on Agriculture and Health, LCIRAH), food chain risk assessments, and integrated disease surveillance, among other areas. Researchers are mapping the path of meat and milk products, and their associated disease risks in Nairobi. Through this, they hope to better understand how
diseases emerge in order to prevent future outbreaks.
“We’re redrawing the map of Nairobi, not based on geography, but on the connectedness of animal and human populations, in terms of bacteria that they share.” Eric Fèvre
Featured in the A4NH 2014 Annual report on page 23. You can read the report by clicking here

Food Standard Agency reveals Campylobacter in third of supermarket chicken

Food Standard Agency reveals Campylobacter in third of supermarket chicken

Poultry value chainPaul Wigley, Professor of Avian Infection and Immunity at the University of Liverpool, said: “The results of the FSA study are of little surprise. Campylobacter infection is endemic in chicken production and similar levels are found in other EU countries with large poultry industries.

“Although the FSA and poultry producers take the problem seriously, the biology of this bug makes its control extremely difficult. Whilst a few hundred bacteria can make someone ill, chickens may carry many millions of the bug with relatively little disease.

“Our understanding of the behaviour of the bacterium in the environment and how its spreads into chicken production are poorly understood and despite its importance we know surprisingly little of how it behaves in the chicken.

“The controls that have been very successful in reducing Salmonella levels in chicken including good hygiene practice and biosecurity are less effective for Campylobacter. Most importantly we do not have a vaccine for Campylobacter, something which has been key to the reduction of Salmonella in chicken production over the last 20 years.

“We clearly know the extent of the problem and that the bug is common in all forms of chicken production including organic and free range production.  Whilst some of the solutions, such as surface chilling, may be beneficial in the short term, longer term we need investment in more effective controls, such as vaccines.

“In the meantime the advice on handling and cooking poultry from FSA should be followed to reduce the risk from this nasty bug.”

Full article can be viewed by clicking here

Genomic data reveals emergence in Africa of drug resistant strain of typhoid

Genomic data reveals emergence in Africa of drug resistant strain of typhoid

Genomic_IGH

The University of Liverpool and Liverpool School of Tropical Medicine, in partnership with the Wellcome Trust Sanger Institute, have revealed the emergence of a novel strain of Typhoid fever in Malawi, Africa.

The team has completed two genomics studies on the tropical disease, a condition that is estimated to cause up to 30 million illnesses and over a quarter of a million deaths globally each year.

The first study, published in the journal Nature Genetics, suggests that the H58-strain, which is likely to have emerged in Asia approximately thirty years ago, is now rapidly spreading across Africa, where it has been introduced on several separate occasions. A key feature of this strain appears to be its ability to acquire resistance to commonly available antibiotics.

Genetic package

Dr Melita Gordon, from the University of Liverpool’s Institute of Infection and Global Health, said: “Importantly, the antibiotic resistance genes, which have previously been carried on a separate genetic package, have now been incorporated into the main chromosome of the bacteria itself, which is likely to make it easier for the Typhoid strain to retain these resistance genes.”

Data from the microbiology laboratory at the Malawi-Liverpool-Wellcome Trust Major Overseas Programme, where bloodstream infections have been monitored for 18 years, show that an epidemic of Typhoid fever began in Malawi in 2011.

In a related study, published in the journal PLoS Neglected Tropical Diseases, the team has investigated the epidemic and the re-emergence of the disease in Malawi by studying the genomes of the bacteria.

Large epidemic

Genomic data from the Malawi strains reveals that up until 2009 no H58 strains were found, and other local strains of Salmonella Typhi were fully sensitive to the antibiotics used locally.

After 2010, a large number of different strains, however, appeared in Blantyre, competing for dominance. H58 emerged as the most successful strain, triggering a large epidemic in which up to 800 cases occurred per year, with a 3% case fatality.

Dr Nick Feasey, from the Liverpool School of Tropical Medicine said: “The rise of antibiotic resistance among Salmonellae in Africa is a major threat and concern. Not only does it mean that individuals cannot always be effectively treated, but it also appears to make global spread and large epidemics more likely.”

Liverpool scientists are now conducting further work at the Malawi-Liverpool-Wellcome Trust Clinical Research Programme, funded by a £4 million Strategic Award from the Wellcome Trust, as part of a team led by the University of Oxford Vaccine Group, to investigate the best ways to use future vaccines to halt the spread of multidrug resistant Typhoid fever in Africa.

View this article at the IGH News section by clicking here

Pin It on Pinterest